Serveur d'exploration SRAS - Analysis (2020)

Index « Auteurs » - entrée « Taisheng Li »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Taijiao Jiang < Taisheng Li < Tak Hong Cheong  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000267 (2020) Lin Qiu [République populaire de Chine] ; Xia Liu [République populaire de Chine] ; Meng Xiao [République populaire de Chine] ; Jing Xie [République populaire de Chine] ; Wei Cao [République populaire de Chine] ; Zhengyin Liu [République populaire de Chine] ; Abraham Morse [États-Unis] ; Yuhua Xie ; Taisheng Li [République populaire de Chine] ; Lan Zhu [République populaire de Chine]SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection.
000580 (2020) Ling Lin [République populaire de Chine] ; Lianfeng Lu [République populaire de Chine] ; Wei Cao [République populaire de Chine] ; Taisheng Li [République populaire de Chine]Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.
000823 (2020) Taisheng Li [République populaire de Chine] ; Hongzhou Lu [République populaire de Chine] ; Wenhong Zhang [République populaire de Chine]Clinical observation and management of COVID-19 patients.

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Coronavirus Infections (drug therapy)
2Coronavirus Infections (therapy)
2Humans
2Pandemics
2Pneumonia, Viral (drug therapy)
2Pneumonia, Viral (therapy)
1Animals
1Antibodies, Viral (blood)
1Antibodies, Viral (immunology)
1Anticoagulants (therapeutic use)
1Antiviral Agents (therapeutic use)
1B-Lymphocytes (immunology)
1Betacoronavirus
1Betacoronavirus (pathogenicity)
1China
1Clinical Trials as Topic
1Coronavirus Infections (immunology)
1Coronavirus Infections (mortality)
1Coronavirus Infections (physiopathology)
1Coronavirus Infections (virology)
1Critical Illness
1Cytokines (immunology)
1Cytokines (metabolism)
1Disease Progression
1Female
1Glucocorticoids (therapeutic use)
1Heparin, Low-Molecular-Weight (therapeutic use)
1Immunoglobulins, Intravenous (therapeutic use)
1Immunologic Factors (therapeutic use)
1Influenza A Virus, H1N1 Subtype
1Influenza, Human (immunology)
1Male
1Medicine, Chinese Traditional
1Mice
1Middle East Respiratory Syndrome Coronavirus (immunology)
1Patient Care Management
1Patient Care Team
1Pneumonia, Viral (immunology)
1Pneumonia, Viral (mortality)
1Pneumonia, Viral (physiopathology)
1Pneumonia, Viral (virology)
1SARS Virus (immunology)
1Severe Acute Respiratory Syndrome (immunology)
1T-Lymphocytes (immunology)
1Thrombophilia (physiopathology)
1Thrombophilia (therapy)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Author.i -k "Taisheng Li" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Author.i  \
                -Sk "Taisheng Li" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Taisheng Li
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021